| Similar Articles |
|---|
 |
Bio-IT World
February 11, 2005
Prashant Tyagi |
Can Life Sciences Go the IT Way? Guest commentary: lessons for guiding the revolution in biotechnology and other life science disciplines.   |
Bio-IT World
November 12, 2002
James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success. |
| Knowledge@Wharton |
A New Approach to Valuing Biotech Stocks Enormous swings in biotechnology stock prices during the last few weeks show how difficult it is for investors to value biotech companies. It's important to understand the invisible potential locked up in the organizational structure of biotechnology companies... |
Food Processing
June 2011
Bob Sperber |
Modular Automation Allows for Food Manufacturing Flexibility From the PC to the Internet revolution, standard, modular software objects are the key to easier manufacturing agility and integration. |
Bio-IT World
March 10, 2003
Bernard P. Wess Jr. |
Web Services: Antidote for Anarchy The rapid growth of biopharma, health care, and regulatory systems has resulted in process and information anarchy. Strategically applying an enterprisewide IT architecture can reduce costs and complexity. |
Information Today
April 5, 2012
Marydee Ojala |
Northern Light Introduces Discovery Portals The discovery portals use the sophisticated search capabilities developed by Northern Light over the past decade, with full Boolean capabilities, field limitations, and faceted navigation. |
Bio-IT World
March 2006 |
Bio-IT World Bio-IT 50 The 50 companies profiled here have driven and continue to drive the future of biomedical research and drug discovery: Accelrys... Affymetrix.. Apple... Becton Dickinson... BlueArc... 454 Life Sciences... etc. |
Bio-IT World
November 12, 2002
Michael Goldman |
A Virtual Pharmacopeia Computational modeling of disease pathways, organs --- even patients --- could transform drug discovery. Does salvation exist in silico? |
Bio-IT World
November 2006
Kevin Davies |
Building a Bridge Over Pharma with IT More than 100 enthusiastic delegates bridging the full breadth of the drug development pipeline gathered recently for the second annual Bridging Pharma and IT conference. Here are some highlights. |
Bio-IT World
Dec 2006/Jan 2007 |
Resolute in the New Year Industry leaders in areas from pharmacogenetics to cheminformatics found 2006 to be a year of important steps forward, but looked with even more anticipation to 2007: Allen D. Roses, SVP, Pharmacogenetics GlaxoSmithKline... etc. |
D-Lib
September 2003
Kevin Boyack |
Mapping Scientific Frontiers: The Quest for Knowledge Visualization Information visualization is a new field, and its techniques can help us understand the process of science in the making. In his new book, Chaomei Chen takes us on a journey through this history, touching on predecessors, and then leading us firmly into the new world of Mapping Scientific Frontiers. |
Bio-IT World
July 11, 2002
Kevin Davies |
Counting the Cost of Drug Discovery Much of the trouble ensnaring the drug industry is blamed on the exorbitant cost of drug discovery. Tangible proof that the bio-IT revolution will economize drug discovery is emerging, but there is still a long way to go. |
IEEE Spectrum
November 2005
Amy D. Wohl |
Interface Lift User interfaces for Internet browsers get an extreme makeover to cope with today's torrent of information. |
Bio-IT World
September 9, 2002
John P. Helfrich |
Data Management in High-Throughput Screening The high-throughput drug discovery field requires an optimal IT platform. |
Bio-IT World
November 2006
Alan S. Louie |
Signs of Life in Life Sciences IT Spending Pharmaceutical and other life science companies are confronting explosive growth in the volume of data being generated from R&D programs including high-throughput discovery instrumentation, molecular imaging (pre-clinical and clinical), and access to external data sources. |
Bio-IT World
July 2005
Salvatore Salamone |
Visualize This An attractive combination of features -- high performance, component standardization, and the ability to access large amounts of memory -- is making new visualization systems appealing for many computationally intensive biomedical applications. |
Bio-IT World
November 12, 2002
Debra Goldfarb |
Disruption --The Real Revolution What is the real promise of the genomic revolution? It is its power to unleash disruptive innovation -- technology that allows a new group of people with different skill sets to do things in a decentralized, less expensive way. |
Bio-IT World
October 2005 |
News Blast One Stop... New Strand... Emerging... Appointment... |
CIO
July 15, 2002
Christopher Lindquist |
Creative Visualizatio Spotfire analysis tools turn complex data into pretty -- and powerful -- pictures. |
